Pharmaceutical Industry

Page 38 of 100

FDA Sarepta Drug Approval Controversy
Newsletters

Does the FDA need to slow its drug approval roll?

By
January 22, 2020
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
Magazine

Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?

By
January 20, 2020
JPM 2020
Newsletters

Biopharma’s big week is upon us

By
January 13, 2020
FDA Drug Approvals 2019
Newsletters

The FDA Kept Up Its Drug Approval Streak In 2019

By
January 7, 2020
A heart graphic is seen displayed on an Apple Watch in this photo illustration in Warsaw, Poland on April 25, 2019.
Commentary

Pharma needs to stop chasing shiny objects and start embracing practical technology

By
January 7, 2020
Big-Pharma-Prescription-Drugs
Health

Big Pharma Raised Prices of Several Prescription Drugs on First Day of 2020

By
January 2, 2020
Sarepta Stock Roche Deal
Health

Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal

By
December 23, 2019
Big Pharma ROI
Newsletters

Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low

By
December 18, 2019
Multiple myeloma MMRF
Newsletters

GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug

By
December 18, 2019
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
Health

Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors

By David Eggert and The Associated Press
December 17, 2019
Drugs and Tech Revolutionizinf Healthcare
Health

The 4 Most Game-Changing Medical Advances of the Past Decade

By
December 17, 2019
Duchenne Sarepta FDA
Newsletters

FDA Approves Sarepta Duchenne Drug in Stunning Reversal

By
December 14, 2019
New British Chief Executive Officer of French pharmaceutical group Sanofi Paul Hudson talks to journalists at Sanofi headquarters in Paris on October 1, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
International

Why Sanofi’s New CEO Is Trading Diabetes Drugs for Cancer Breakthroughs

By James Paton and Bloomberg
December 10, 2019
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
Health

Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology

By Riley Griffin, James Paton and Bloomberg
December 9, 2019
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
International

Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value

By James Paton and Bloomberg
December 9, 2019

Most Popular